干扰素正越来越接近于实现它在临床上的潜在作用。Alick和Jean Lindenmann发现干扰素22年后,麻省总医院的一个研究小组已发现,干扰素可能有助于保护肾脏移植的受植者,使之免受感染。干扰素的临床应用,进展缓慢而艰难,主要原因在于得来不易,因此价值昂贵。表面看来,各种细胞都产生干扰素,但其量极少。看来它还具有种的特异性,因此用于人 Interferons are getting closer and closer to realizing its potential role in the clinic. 22 years after Alick and Jean Lindenmann discovered interferon, a team at the Massachusetts General Hospital has found that interferons may help protect the kidney transplant recipients from infection. The clinical application of interferon, slow and difficult progress, the main reason is not easy to come by, so expensive. On the surface, all kinds of cells produce interferon, but in very small quantities. It also appears to be species-specific and therefore used in humans